HCPCS G9090: Rectal Adenocarcinoma Disease Status, T1-2 N0 M0

HCPCS Level II code G9090 denotes documentation of disease status for rectal cancer limited to invasive adenocarcinoma with initial staging of T1‑2, N0, M0 and no evidence of progression, recurrence, or metastasis. The code is designated for use in a Medicare‑approved demonstration project and formalizes reporting of early, localized rectal adenocarcinoma status prior to any neo‑adjuvant therapy. Nationally, accurate capture of disease status codes like G9090 supports programmatic evaluation, quality measurement, and targeted coverage decisions for oncology care pathways.

Key payers addressed in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find clinical context about the staging and intended use of the code, guidance on typical sites of service, and a summary of commonly applied modifiers and payer considerations. The publication also summarizes how this code fits into oncology service lines and what stakeholders can expect when documenting initial, localized rectal cancer status within demonstration or pilot programs.

This overview is written for a national audience and focuses on the code's clinical meaning, reporting purpose, and relevance to payer program operations and quality reporting.

Billing Code Overview

HCPCS Level II code G9090 describes oncology disease staging for rectal cancer limited to invasive cancer with adenocarcinoma as the predominant cell type, with extent of disease initially established as T1-2, N0, M0 (prior to neo‑adjuvant therapy, if any) and with no evidence of disease progression, recurrence, or metastases. This code is intended for use in a Medicare‑approved demonstration project.

Service Type

The service represented is an oncology disease status assessment / staging determination documenting initial localized rectal adenocarcinoma (T1‑2, N0, M0) with no progression, recurrence, or metastasis.

Typical Site of Service

The typical site of service for this assessment is an oncology clinic or hospital outpatient setting where initial diagnostic staging and documentation for rectal cancer are performed prior to neo‑adjuvant therapy.

Clinical Context

A 62-year-old patient with biopsy-proven rectal adenocarcinoma is evaluated in a multidisciplinary oncology demonstration project. Initial staging with endorectal ultrasound and pelvic MRI establishes tumor limited to the rectal wall without regional nodal involvement or distant metastasis, documented as clinical stage T1-2 N0 M0 prior to any neo-adjuvant therapy. The patient is referred to colorectal surgery and medical oncology for treatment planning; the demonstration-project reporting event captures disease status (no progression, recurrence, or metastases) using billing code G9090. Typical workflow: initial diagnostic workup (history, physical exam, colonoscopy with biopsy), imaging (pelvic MRI, chest/abdominal CT), tumor board review documenting clinical stage T1-2 N0 M0, entry into the Medicare-approved demonstration project registry, ongoing surveillance visits documenting absence of progression or recurrence, and potential surgical resection or local excision coordinated by colorectal surgery. Sites of service commonly include outpatient oncology clinics, colorectal surgery clinics, hospital-based outpatient departments, and academic cancer centers participating in the demonstration project. Common patient modifiers that may affect billing include those reflecting anesthesia, professional versus technical components, service reduced or discontinued, and unusual procedural services (00, 22, 52, 53, 62, AS, QK, QX).

Coding Specifications

Modifier table

Modifier	Description	When to Use
`00`	Default or not otherwise specified modifier	Use when no applicable modifier is reported; code present in input list but not typically appended clinically
`22`	Increased procedural services	When work or time substantially exceeds the usual for documentation or reporting of complex staging assessments or prolonged coordination for demonstration project enrollment
`23`	Unusual anesthesia	When a procedure requires general anesthesia for patient safety during staging or local resection in the demonstration protocol
`52`	Reduced services	When a planned diagnostic or staging procedure is partially reduced or not completed
`53`	Discontinued procedure	When a procedure is started but terminated due to patient condition or intra-procedural findings before completion
`54`	Surgical care only	When only the surgeon’s intraoperative portion is billed and postoperative care is billed separately
`55`	Postoperative management only	When only postoperative care is billed (e.g., surgeon follow-up after initial staging/surgery)
`56`	Preoperative management only	When only preoperative evaluation is billed (e.g., staging visit prior to surgery)
`62`	Two surgeons	When two surgeons with distinct skills are required for resection after staging confirms `T1-2 N0 M0` disease
`AS`	Physician assistant, nurse practitioner, or clinical nurse specialist services with facility	When an advanced practice clinician provides services in the facility setting for staging or follow-up
`QK`	Medical direction of two, three, or four assistants at surgery	When physician directs multiple surgical assistants during resection following staging
`QX`	Surgical assistant — assistant at surgery	When a qualified assistant at surgery participates during resection
`QY`	Medical documentation laparoscopic/endoscopic assistant (specific program)	When documentation supports an assistant participating per program rules

Provider taxonomy table

Taxonomy Code	Specialty	Notes
`207V00000X`	Colon and Rectal Surgery	Primary surgical specialty performing local excision or resection after staging
`207L00000X`	Gastroenterology	Performs diagnostic colonoscopy, biopsy, and contributes to staging workup
`207P00000X`	Medical Oncology	Manages neoadjuvant/adjuvant therapy decisions and participates in demonstration project care coordination
`208000000X`	Family Medicine	May provide longitudinal surveillance visits and coordinate referrals in community settings
`363LP0200X`	Registered Nurse (Oncology)	Provides clinical care coordination and documentation for demonstration project reporting

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`C20`	Malignant neoplasm of rectum	Primary diagnosis for rectal adenocarcinoma limited to the rectum; core indication for staging and demonstration project reporting
`C19`	Malignant neoplasm of rectosigmoid junction	Relevant when tumor location spans rectosigmoid junction but management and staging may be similar
`D01.0`	Carcinoma in situ of colon	Represents very early neoplastic change; included for differential considerations during staging and surveillance
`K50.90`	Crohn disease, unspecified, without complications	Chronic inflammatory conditions of the bowel that may complicate evaluation, surveillance, or surgery planning
`K57.30`	Diverticulosis of large intestine (without perforation or abscess)	Common comorbidity affecting colon/rectal evaluation and procedural planning
`Z85.038`	Personal history of malignant neoplasm of large intestine	Relevant for surveillance and demonstration-project eligibility in patients with prior colorectal cancer
`Z12.11`	Encounter for screening for malignant neoplasm of colon	Screening encounters that may lead to diagnosis and staging; part of clinical workflow leading to `G9090` reporting

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`45380`	Colonoscopy, flexible; with biopsy, single or multiple	Performed during diagnostic workup to obtain tissue diagnosis prior to staging and demonstration project enrollment
`76881`	Ultrasound, transrectal; complete	Endorectal ultrasound used to assess depth of tumor invasion (T-category) for staging `T1-2` disease
`74177`	CT abdomen and pelvis with contrast	Cross-sectional imaging to exclude regional nodal disease or distant metastases as part of staging workup
`72195`	MRI pelvis without contrast (or with and without contrast, if applicable)	Pelvic MRI to assess local extent of rectal tumor and mesorectal fascia involvement for accurate `T` staging
`44140`	Colectomy, partial; with anastomosis (low anterior resection)	Common definitive surgical resection performed after staging confirms localized disease; may follow documentation under `G9090`
`45385`	Colonoscopy, flexible; with removal of tumor by hot biopsy forceps or snare	Local excision or polypectomy techniques used for small, early `T1` lesions in selected cases as part of treatment pathway

OpenPayer

Summary & Overview